Jan Braune
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.
Journal: Blood cancer journal
Published: June 03, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.
Journal: Molecular cancer therapeutics
Published: April 08, 2025
Detection of autoantibodies against Interferon Type I in patients with autochthonous West Nile Virus encephalitis.
Journal: Brain, behavior, & immunity - health
Published: March 24, 2025
SARS-CoV-2 mRNA vaccination-induced immunological memory in human nonlymphoid and lymphoid tissues.
Journal: The Journal of clinical investigation
Published: April 26, 2023
Relapse of NPM1-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Case reports in hematology
Published: August 22, 2022
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma.
Journal: Blood advances
Published: April 15, 2022
Circulating Tumor DNA Allows Early Treatment Monitoring in BRAF- and NRAS-Mutant Malignant Melanoma.
Circulating Tumor DNA Allows Early Treatment Monitoring in BRAF- and NRAS-Mutant Malignant Melanoma.
Journal: JCO precision oncology
Published: November 01, 2020
Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management.
Journal: Diagnostics (Basel, Switzerland)
Published: June 26, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026